Atossa Accounts Payable vs Short Term Debt Analysis

ATOS Stock

USD 1.30 0.02 1.56%

Atossa Genetics financial indicator trend analysis is way more than just evaluating Atossa Genetics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Atossa Genetics is a good investment. Please check the relationship between Atossa Genetics Accounts Payable and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Accounts Payable vs Short Term Debt

Accounts Payable vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Atossa Genetics Accounts Payable account and Short Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Atossa Genetics' Accounts Payable and Short Term Debt is -0.45. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Atossa Genetics, assuming nothing else is changed. The correlation between historical values of Atossa Genetics' Accounts Payable and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Atossa Genetics are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Accounts Payable i.e., Atossa Genetics' Accounts Payable and Short Term Debt go up and down completely randomly.

Correlation Coefficient

-0.45

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Atossa Genetics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Atossa Genetics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Debt

Most indicators from Atossa Genetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Atossa Genetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.Sales General And Administrative To Revenue is likely to gain to 4,756 in 2024, whereas Selling General Administrative is likely to drop slightly above 8.7 M in 2024.

	2023	2024 (projected)
Interest Income	3.8M	4.0M
Non Recurring	415.5K	394.8K

Interest Income Non Recurring

Atossa Genetics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant And Equipment Net	Accounts Payable	Net Receivables	Short Term Investments	Inventory	Other Current Assets
Total Assets		-0.29	0.23	0.34	1.0	-1.0	-0.84	1.0	0.33	0.55	0.58	1.0	0.95	0.96	0.62	0.94	0.34	1.0	-0.36	0.96	-0.47	0.78	0.45	-0.31	0.8	0.86
Short Long Term Debt Total	-0.29		-0.2	-0.2	-0.28	0.28	0.42	-0.28	-0.31	-0.19	-0.23	-0.28	-0.28	-0.25	-0.03	-0.38	-0.2	-0.28	0.45	-0.27	0.05	-0.29	-0.31	0.77	-0.05	-0.25
Other Current Liab	0.23	-0.2		0.98	0.16	-0.23	-0.39	0.23	-0.09	0.11	0.03	0.23	0.37	0.13	0.09	0.3	0.98	0.23	-0.24	0.27	-0.31	0.42	0.21	-0.19	0.34	0.34
Total Current Liabilities	0.34	-0.2	0.98		0.27	-0.34	-0.46	0.34	-0.03	0.13	0.11	0.34	0.45	0.22	0.14	0.39	1.0	0.34	-0.27	0.36	-0.26	0.57	0.31	-0.23	0.47	0.48
Total Stockholder Equity	1.0	-0.28	0.16	0.27		-1.0	-0.83	1.0	0.34	0.54	0.58	1.0	0.94	0.96	0.62	0.93	0.27	1.0	-0.34	0.95	-0.47	0.76	0.44	-0.3	0.79	0.84
Net Debt	-1.0	0.28	-0.23	-0.34	-1.0		0.83	-1.0	-0.28	-0.51	-0.54	-1.0	-0.94	-0.95	-0.58	-0.93	-0.34	-1.0	0.38	-0.94	0.48	-0.79	-0.48	0.3	-0.81	-0.86
Retained Earnings	-0.84	0.42	-0.39	-0.46	-0.83	0.83		-0.84	-0.26	-0.72	-0.7	-0.84	-0.91	-0.87	-0.72	-0.97	-0.46	-0.84	0.6	-0.9	0.56	-0.66	-0.35	0.48	-0.63	-0.66
Cash	1.0	-0.28	0.23	0.34	1.0	-1.0	-0.84		0.29	0.53	0.56	1.0	0.95	0.95	0.6	0.94	0.34	1.0	-0.38	0.95	-0.49	0.78	0.46	-0.3	0.8	0.85
Non Current Assets Total	0.33	-0.31	-0.09	-0.03	0.34	-0.28	-0.26	0.29		0.52	0.64	0.29	0.36	0.43	0.57	0.31	-0.03	0.29	0.31	0.39	0.2	0.24	-0.29	-0.4	0.11	0.38
Non Currrent Assets Other	0.55	-0.19	0.11	0.13	0.54	-0.51	-0.72	0.53	0.52		0.9	0.53	0.73	0.73	0.88	0.69	0.13	0.53	-0.27	0.75	-0.27	0.18	-0.35	-0.22	0.18	0.25
Other Assets	0.58	-0.23	0.03	0.11	0.58	-0.54	-0.7	0.56	0.64	0.9		0.56	0.7	0.74	0.89	0.69	0.11	0.56	-0.35	0.72	-0.14	0.41	-0.22	-0.3	0.33	0.45
Cash And Short Term Investments	1.0	-0.28	0.23	0.34	1.0	-1.0	-0.84	1.0	0.29	0.53	0.56		0.95	0.95	0.6	0.94	0.34	1.0	-0.38	0.95	-0.49	0.78	0.46	-0.3	0.8	0.85
Common Stock Total Equity	0.95	-0.28	0.37	0.45	0.94	-0.94	-0.91	0.95	0.36	0.73	0.7	0.95		0.97	0.75	0.96	0.45	0.95	-0.38	0.99	-0.53	0.7	0.26	-0.29	0.72	0.77
Common Stock Shares Outstanding	0.96	-0.25	0.13	0.22	0.96	-0.95	-0.87	0.95	0.43	0.73	0.74	0.95	0.97		0.79	0.95	0.22	0.95	-0.35	0.99	-0.49	0.67	0.23	-0.26	0.71	0.76
Non Current Liabilities Total	0.62	-0.03	0.09	0.14	0.62	-0.58	-0.72	0.6	0.57	0.88	0.89	0.6	0.75	0.79		0.71	0.14	0.6	-0.22	0.78	-0.4	0.41	-0.27	-0.06	0.45	0.48
Other Stockholder Equity	0.94	-0.38	0.3	0.39	0.93	-0.93	-0.97	0.94	0.31	0.69	0.69	0.94	0.96	0.95	0.71		0.39	0.94	-0.52	0.96	-0.54	0.72	0.39	-0.43	0.71	0.76
Total Liab	0.34	-0.2	0.98	1.0	0.27	-0.34	-0.46	0.34	-0.03	0.13	0.11	0.34	0.45	0.22	0.14	0.39		0.34	-0.28	0.36	-0.26	0.57	0.31	-0.23	0.47	0.48
Total Current Assets	1.0	-0.28	0.23	0.34	1.0	-1.0	-0.84	1.0	0.29	0.53	0.56	1.0	0.95	0.95	0.6	0.94	0.34		-0.38	0.95	-0.49	0.78	0.47	-0.3	0.81	0.85
Short Term Debt	-0.36	0.45	-0.24	-0.27	-0.34	0.38	0.6	-0.38	0.31	-0.27	-0.35	-0.38	-0.38	-0.35	-0.22	-0.52	-0.28	-0.38		-0.37	0.29	-0.45	-0.38	0.25	-0.32	-0.25
Common Stock	0.96	-0.27	0.27	0.36	0.95	-0.94	-0.9	0.95	0.39	0.75	0.72	0.95	0.99	0.99	0.78	0.96	0.36	0.95	-0.37		-0.52	0.67	0.23	-0.28	0.71	0.75
Property Plant And Equipment Net	-0.47	0.05	-0.31	-0.26	-0.47	0.48	0.56	-0.49	0.2	-0.27	-0.14	-0.49	-0.53	-0.49	-0.4	-0.54	-0.26	-0.49	0.29	-0.52		-0.32	-0.24	-0.04	-0.53	-0.39
Accounts Payable	0.78	-0.29	0.42	0.57	0.76	-0.79	-0.66	0.78	0.24	0.18	0.41	0.78	0.7	0.67	0.41	0.72	0.57	0.78	-0.45	0.67	-0.32		0.61	-0.29	0.88	0.94
Net Receivables	0.45	-0.31	0.21	0.31	0.44	-0.48	-0.35	0.46	-0.29	-0.35	-0.22	0.46	0.26	0.23	-0.27	0.39	0.31	0.47	-0.38	0.23	-0.24	0.61		-0.4	0.59	0.54
Short Term Investments	-0.31	0.77	-0.19	-0.23	-0.3	0.3	0.48	-0.3	-0.4	-0.22	-0.3	-0.3	-0.29	-0.26	-0.06	-0.43	-0.23	-0.3	0.25	-0.28	-0.04	-0.29	-0.4		-0.01	-0.27
Inventory	0.8	-0.05	0.34	0.47	0.79	-0.81	-0.63	0.8	0.11	0.18	0.33	0.8	0.72	0.71	0.45	0.71	0.47	0.81	-0.32	0.71	-0.53	0.88	0.59	-0.01		0.92
Other Current Assets	0.86	-0.25	0.34	0.48	0.84	-0.86	-0.66	0.85	0.38	0.25	0.45	0.85	0.77	0.76	0.48	0.76	0.48	0.85	-0.25	0.75	-0.39	0.94	0.54	-0.27	0.92

Click cells to compare fundamentals

Atossa Genetics Account Relationship Matchups

Atossa Genetics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.5M	42.8M	141.3M	123.5M	96.3M	101.1M
Other Current Liab	12.9K	14.0M	1.4M	2.6M	4.4M	2.5M
Total Current Liabilities	1.3M	15.7M	3.1M	5.6M	5.2M	3.6M
Total Stockholder Equity	13.2M	27.2M	138.1M	118.0M	91.0M	95.6M
Net Debt	(12.5M)	(39.5M)	(136.4M)	(110.9M)	(88.5M)	(84.0M)
Retained Earnings	(94.1M)	(111.9M)	(129.2M)	(156.2M)	(186.3M)	(177.0M)
Cash	12.6M	39.6M	136.4M	110.9M	88.5M	92.9M
Non Current Assets Total	170.2K	69.3K	22K	5.3M	4.0M	4.2M
Other Assets	350.0	0.0	2K	635K	730.3K	766.8K
Cash And Short Term Investments	12.6M	39.6M	136.4M	110.9M	88.5M	92.9M
Common Stock Total Equity	1.1M	1.6M	13.0M	22.8M	26.2M	27.5M
Common Stock Shares Outstanding	8.5M	11.3M	117.0M	126.6M	126.1M	132.4M
Liabilities And Stockholders Equity	14.5M	42.8M	141.3M	123.5M	96.3M	101.1M
Non Current Liabilities Total	11.1K	3.8K	1K	3.0M	3.4M	3.6M
Other Stockholder Equity	105.6M	129.9M	244.0M	250.8M	254.5M	267.2M
Total Liab	1.3M	15.7M	3.1M	5.6M	5.2M	3.6M
Total Current Assets	14.3M	42.8M	141.2M	118.2M	92.2M	96.8M
Common Stock	1.1M	1.6M	8.6M	22.8M	26.2M	27.5M
Property Plant And Equipment Net	54.5K	84.5K	38.7K	20K	18K	17.1K
Accounts Payable	293.2K	1.6M	1.7M	3.0M	806K	834.6K
Net Receivables	739.7K	634.9K	1.1M	743K	(1.5K)	(1.4K)
Inventory	972.3K	1.9M	2.6M	4.1M	1.5M	1.1M
Other Current Assets	26.1K	2.5M	3.8M	6.6M	2.3M	1.4M
Property Plant And Equipment Gross	54.5K	84.5K	20.6K	36K	32.4K	30.8K
Intangible Assets	75.7K	99.4K	68.5K	13.4K	12.0K	11.4K
Property Plant Equipment	54.5K	34.4K	38.7K	20K	18K	17.1K
Net Tangible Assets	13.2M	26.5M	137.6M	118.0M	135.7M	142.4M
Retained Earnings Total Equity	(94.1M)	(111.9M)	(129.2M)	(156.2M)	(140.6M)	(133.5M)
Capital Surpluse	105.6M	130.5M	244.6M	251.4M	289.1M	303.5M
Net Invested Capital	13.2M	27.2M	138.1M	118.0M	135.7M	142.4M
Net Working Capital	13.0M	27.1M	138.1M	112.6M	129.5M	136.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC